| Session: Inhibitors of Bacterial and Fungal Efflux Pumps Location:
 Exhibit Hall
 Session Date:
 Monday, 9/27/99
 Session Time:
 3:00 pm - 4:30 pm
 
 Prevalence of Efflux Pumps among Clinical Isolates of
 Fluoroquinolone-Resistant Pseudomonas aeruginosa
 
 D. Cho, J. Blais, K. Tangen, C. Ford, A. Lee, O. Lomovskaya, S. Chamberland,
 G.H. Miller
 Microcide Pharmaceuticals, Inc.: Mountain View, CA
 
 Active efflux plays an important role in intrinsic and acquired resistance of Pseudomonas
 aeruginosa to a wide variety of antimicrobial agents. There are three well-characterized
 efflux systems involved in multidrug resistance in P. aeruginosa: MexAB-OprM,
 MexCD-OprJ, and MexEF-OprN. Another efflux system, MexXY has also recently
 been reported. We determined the frequency of efflux-mediated resistance in 409 recent
 clinical isolates of P. aeruginosa obtained from 12 countries (USA, Japan, Thailand,
 Canada, Greece, China, France, Argentina, UK, Venezuela, Turkey, and Spain). Efflux
 pump profiles were based upon susceptibility to 10 antibiotics (piperacillin, carbenicillin,
 ceftazidime, aztreonam, imipenem, meropenem, chloramphenicol, erythromycin,
 ciprofloxacin, and levofloxacin) and response to broad-spectrum and pump-specific
 efflux pump inhibitors (EPIs). 56 laboratory mutants with known genotypes and varied
 pump expression were used to establish criteria for each pump profile. The MexAB
 profile was the most prevalent among these isolates (296 or 72%) while the
 MexAB/MexCD profile was observed in 9% (36) of the isolates. The remaining isolates
 were divided as follows: 17 (4%) AB/EF, 15 (4%) AB/CD/EF, 14 (3%) CD, 9 (2%)
 CD/EF, 3 (<1%) EF, and 19 (5%) other pumps (responding to a broad-spectrum EPI
 only). Breakdown of profiles by geographic origin revealed significant variation in pump
 profiles from region to region. For example, the MexAB profile was found in only 27%
 of isolates from China but in 96% of isolates from Japan. These results show that
 Mex-type efflux pumps are highly prevalent among worldwide isolates of
 fluoroquinolone-resistant P. aeruginosa.
 |